Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors

NCT03932565 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Nectin4-positive Advanced Malignant Solid Tumor

Interventions

BIOLOGICAL: CAR-T therapy for nectin4-positive malignant solid tumor

Sponsor

The Sixth Affiliated Hospital of Wenzhou Medical University

Collaborators

[object Object]